Atlas Trials

Intravitreal Bevacizumab for Nonproliferative Diabetic Retinopathy

Clinical trial NCT04511715 · UNKNOWN

Trial details

NCT number
NCT04511715
Sponsor
Shahid Beheshti University of Medical Sciences
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Non-proliferative Diabetic Retinopathy
Start date
2020-09-01
Primary completion
2021-01-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.